You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Lymphocytic, Chronic, B-Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ITGA4 Gene Methylation Status in Chronic Lymphocytic Leukemia

Not yet recruiting
  • Chronic Lymphocytic Leukemia
    • (no location specified)
    May 7, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell Trial in Nanjing (JWCAR029 (Relmacabtagene Autoleucel))

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • JWCAR029 (Relmacabtagene Autoleucel)
    • Nanjing, Jiangsu, China
      Jiangsu Province Hospital
    Feb 17, 2022

    Chronic Lymphocytic Leukemia (CLL) Trial

    Completed
    • Chronic Lymphocytic Leukemia (CLL)
      • (no location specified)
      Apr 5, 2022

      Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell Trial in Whittier (Pirtobrutinib, Ibrutinib)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • +3 more
      • Whittier, California
        Innovative Clinical Research Institute
      Aug 8, 2022

      National Acalabrutinib Observational Study

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Non interventional study
      • (no location specified)
      Jun 27, 2022

      Indoleamine 2,3-dioxygenase Activity in Chronic Lymphocytic

      Completed
      • CLL
        • Tampere, Finland
          Tampere university Hospital
        Feb 22, 2022

        Small Lymphocytic Leukemia (SLL), Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI (Duvelisib, Ibrutinib)

        Terminated
        Has Results
        • Small Lymphocytic Leukemia (SLL)
        • Chronic Lymphocytic Leukemia (CLL)
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 15, 2022

        Venetoclax in Patients With Chronic Lymphocytic Leukemia

        Recruiting
        • Chronic Lymphocytic Leukemia
        • Taipei, Taiwan
          National Taiwan University Hospital
        Oct 27, 2021

        Chronic Lymphocytic Leukemia Trial in Madison ([U-13C]glucose, [13C5]glutamine)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • [U-13C]glucose
        • [13C5]glutamine
        • Madison, Wisconsin
          University of Wisconsin
        Jun 15, 2022

        Chronic Lymphocytic Leukemia Trial in Houston (Questionnaire Administration, Ruxolitinib Phosphate)

        Active, not recruiting
        • Chronic Lymphocytic Leukemia
        • Questionnaire Administration
        • Ruxolitinib Phosphate
        • Houston, Texas
          M D Anderson Cancer Center
        Feb 2, 2022

        CLL, Leukemia Trial in Houston (Eltrombopag)

        Completed
        • CLL
        • Leukemia
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Mar 14, 2022

        Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)

        Active, not recruiting
        • Chronic Lymphocytic Leukemia
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Feb 23, 2022

        B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

        Not yet recruiting
        • B-cell Malignancy
        • +7 more
        • (no location specified)
        Oct 26, 2022

        Financial Difficulty in Patients With Blood Cancer

        Recruiting
        • Chronic Lymphocytic Leukemia
        • Multiple Myeloma
          • Chapel Hill, North Carolina
            UNC Medical Center
          Aug 9, 2022

          Chronic Lymphoid Leukemia in Relapse Trial in Tuebingen (Belimumab 200 MG/ML [Benlysta], standard of care)

          Recruiting
          • Chronic Lymphoid Leukemia in Relapse
          • Belimumab 200 MG/ML [Benlysta]
          • standard of care
          • Tuebingen, BW, Germany
            University Hospital Tuebingen, CCU Translational Immunology
          Feb 2, 2022

          Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

          Recruiting
          • Chronic Lymphocytic Leukemia
          • +4 more
            • Bobigny, France
            • +8 more
            Mar 23, 2022

            Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston

            Active, not recruiting
            • Chronic Lymphocytic Leukemia
            • +5 more
            • Houston, Texas
              M D Anderson Cancer Center
            Mar 15, 2022

            Determination of Blood Tumor Cells

            Recruiting
            • Leukemia, Lymphocytic, Chronic, B-Cell
            • Abnormalities Cell Epithelial
              • Zurich, Switzerland
                University Hospital Zurich
              Oct 5, 2021

              Leukemia, Lymphocytic, Chronic, B-Cell Trial in Austria (Bendamustine, Alemtuzumab)

              Completed
              • Leukemia, Lymphocytic, Chronic, B-Cell
              • Innsbruck, Tirol, Austria
              • +6 more
              Feb 15, 2022

              Chronic Lymphocytic Leukemia Stage A(0), Chronic Lymphocytic Leukemia Stage A(I), Chronic Lymphocytic Leukemia Stage A(II) Trial

              Recruiting
              • Chronic Lymphocytic Leukemia Stage A(0)
              • +3 more
              • Low Dose Selenious Yeast Tablets
              • High Dose Selenious Yeast Tablets
              • Shanghai, Shanghai, China
                Zhongshan Hospital
              Nov 26, 2021

              Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

              Active, not recruiting
              • Stage I Chronic Lymphocytic Leukemia
              • +3 more
              • Jacksonville, Florida
                Mayo Clinic in Florida
              Mar 24, 2022

              Acalabrutinib in Chronic Lymphocytic Leukaemia in United Kingdom

              Not yet recruiting
              • Chronic Lymphocytic Leukemia, CLL
              • (no location specified)
              Sep 27, 2022

              Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in New York (Ibrutinib, Pembrolizumab)

              Recruiting
              • Chronic Lymphocytic Leukemia
              • Mantle Cell Lymphoma
              • New York, New York
                Icahn School of Medicine at Mount Sinai
              Aug 22, 2022

              Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Small

              Recruiting
              • Recurrent Chronic Lymphocytic Leukemia
              • +4 more
              • Jacksonville, Florida
                Mayo Clinic in Florida
              Mar 22, 2022

              Chronic Lymphocytic Leukemia Trial in Columbus (biological, drug, other)

              Recruiting
              • Chronic Lymphocytic Leukemia
              • Daratumumab
              • +3 more
              • Columbus, Ohio
                Ohio State University Comprehensive Cancer Center
              Feb 24, 2022